14. Usefulness, Limitation and Tumor Specificity of the Combined Measurement of Tumor Markers; CA125, TPA, CEA, Ferritin, SP_1 and SP_5 in Gynecologic Malignancies
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 1986-08-01
著者
-
IJICHI M.
Dept. Obst. & Gynec., Chiba Univ. Sch. Med.
-
Ota Y.
Dept. Obst. and Gynec., Chiba Univ. Sch. Med.
-
Ijichi M.
Dept. Obst. & Gynec. Chiba Naruto Hosp.
関連論文
- 69. Experimental Trial of Radioimmuno-detection and Radioimmunotherapy in Nude Mice with PLC/PRF/5 Hepatoma Cell Line Bearing HBsAg
- 397.Trial Clinical Application of Pregnancy- and Placenta-specific Glycoproteins (SP_1. PP_5,_,_,_) in Trophoblastic Diseases : With Special Reference to Pretherapeutic Differential Diagnosis and Prognosis : XXXXXXVII Trophoblastic Tumor(II)
- 262 Clinical usefulness of various sugar-chains tumor markers.
- 261 The possible clinical application of P-450 in human fetal livers. : compared with present tumor markers.
- 426.Trial Combined Passive and Active Immunization for Preventing Infantile Development of HBV Carrier State by Vertical Transmission : XXXXXXXII Infectious Disease(II)
- 374. Reevaluation of Combined HBIG and HB Vaccine Immunotherapy for Prophylaxis of HBV Vertical Transmission and Infantile Prognostic Factors
- 375 Development of an enzyme immunoassay for placental tissue protein 17 and the possible clinical application.
- 346. Two Membrane Associated Placental Tissue Proteins, MP_1 and PP_4 and Endocrinological Environment
- 182. A Study of Passive and Active Immunization Therapy for Preventing the Infantile Development of HBsAg-carrier State by HB Virus Vertical Transmission from their Mothers
- 14. Usefulness, Limitation and Tumor Specificity of the Combined Measurement of Tumor Markers; CA125, TPA, CEA, Ferritin, SP_1 and SP_5 in Gynecologic Malignancies